Center for Cell and Gene Therapy,
Pathology and Immunology,
Medicine,
Department of Pediatrics
Catherine M. Bollard has not added Biography.
If you are Catherine M. Bollard and would like to personalize this page please email our Author Liaison for assistance.
Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease.
Acta haematologica , 2003 | Pubmed ID: 14583674
Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.
Blood Mar, 2002 | Pubmed ID: 11877273
Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.
Blood May, 2002 | Pubmed ID: 11964281
Current opinion in molecular therapeutics Oct, 2002 | Pubmed ID: 12435048
Immunotherapy for Epstein-Barr virus-associated cancers in children.
The oncologist , 2003 | Pubmed ID: 12604735
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.
Cancer gene therapy Feb, 2004 | Pubmed ID: 14685154
Adoptive immunotherapy for posttransplantation viral infections.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar, 2004 | Pubmed ID: 14993880
The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
Journal of immunotherapy (Hagerstown, Md. : 1997) Jul-Aug, 2004 | Pubmed ID: 15235393
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.
Blood Mar, 2005 | Pubmed ID: 15542583
Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.
The Journal of experimental medicine Dec, 2004 | Pubmed ID: 15611290
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.
Journal of immunology (Baltimore, Md. : 1950) Sep, 2005 | Pubmed ID: 16148164
Adenoviral infections in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar, 2006 | Pubmed ID: 16503493
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
Clinical lymphoma & myeloma Jan, 2006 | Pubmed ID: 16507214
Immunology and cell biology Jun, 2006 | Pubmed ID: 16681825
Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.
Journal of immunotherapy (Hagerstown, Md. : 1997) May-Jun, 2006 | Pubmed ID: 16699368
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
Leukemia & lymphoma May, 2006 | Pubmed ID: 16753867
Adoptive immunotherapy for Hodgkin's lymphoma.
International journal of hematology Jun, 2006 | Pubmed ID: 16787867
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
Nature medicine Oct, 2006 | Pubmed ID: 16998485
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Dec, 2006 | Pubmed ID: 17162209
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) Jul-Aug, 2007 | Pubmed ID: 17589291
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
Blood Oct, 2007 | Pubmed ID: 17609424
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.
Journal of virology Jan, 2008 | Pubmed ID: 17942545
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor.
Journal of immunotherapy (Hagerstown, Md. : 1997) Jun, 2008 | Pubmed ID: 18463534
Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) Feb-Mar, 2008 | Pubmed ID: 18481385
Best practice & research. Clinical haematology Sep, 2008 | Pubmed ID: 18790446
Leukemia & lymphoma , 2008 | Pubmed ID: 18821430
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Nov, 2008 | Pubmed ID: 18940679
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Nov, 2008 | Pubmed ID: 18940685
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
Blood Mar, 2009 | Pubmed ID: 18971421
Journal of immunotherapy (Hagerstown, Md. : 1997) Apr, 2009 | Pubmed ID: 19242369
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.
Blood Aug, 2009 | Pubmed ID: 19443656
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells.
Stem cells (Dayton, Ohio) Aug, 2009 | Pubmed ID: 19544439
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.
Blood Nov, 2009 | Pubmed ID: 19700662
Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU.
Molecular imaging Jul-Aug, 2009 | Pubmed ID: 19728977
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.
Blood Feb, 2010 | Pubmed ID: 19880495
Computer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging.
Academic radiology Apr, 2010 | Pubmed ID: 20060747
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
Blood Apr, 2010 | Pubmed ID: 20110422
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Sep, 2010 | Pubmed ID: 20348004
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.
Leukemia & lymphoma May, 2010 | Pubmed ID: 20367572
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.
Cytotherapy Oct, 2010 | Pubmed ID: 20429793
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.
Journal of immunotherapy (Hagerstown, Md. : 1997) Sep, 2010 | Pubmed ID: 20664358
Blood Nov, 2010 | Pubmed ID: 20671118
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.
Blood Nov, 2010 | Pubmed ID: 20709906
Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.
Cytotherapy Oct, 2010 | Pubmed ID: 20818913
Cytotherapy Nov, 2010 | Pubmed ID: 20942604
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) Nov-Dec, 2010 | Pubmed ID: 20948438
Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.
Journal of immunotherapy (Hagerstown, Md. : 1997) Nov-Dec, 2010 | Pubmed ID: 20948439
Novel cord blood transplant therapies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jan, 2011 | Pubmed ID: 20951821
Blood Feb, 2011 | Pubmed ID: 21310929
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.
Cytotherapy May, 2011 | Pubmed ID: 21361747
Pediatric hematology and oncology Apr, 2011 | Pubmed ID: 21381869
Mediterranean journal of hematology and infectious diseases , 2009 | Pubmed ID: 21416001
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Blood Jun, 2011 | Pubmed ID: 21454450
Cytotherapy Sep, 2011 | Pubmed ID: 21539497
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
The Journal of clinical investigation May, 2011 | Pubmed ID: 21540550
Experimental hematology Oct, 2011 | Pubmed ID: 21767511
Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2011 | Pubmed ID: 21908573
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.
Molecular therapy : the journal of the American Society of Gene Therapy Dec, 2011 | Pubmed ID: 21915103
Aggressive peripheral CD70-positive t-cell lymphoma associated with severe chronic active EBV infection.
Pediatric blood & cancer Oct, 2011 | Pubmed ID: 21994111
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.
Cytotherapy Jan, 2012 | Pubmed ID: 22172091
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Jan, 2012 | Pubmed ID: 22226092
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγnull (NSG) mice.
Experimental hematology Feb, 2012 | Pubmed ID: 22306295
Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) Feb, 2012 | Pubmed ID: 22306904
Good T cells for bad B cells.
Blood Mar, 2012 | Pubmed ID: 22442331
Expert review of hematology Apr, 2012 | Pubmed ID: 22475282
Experimental hematology Apr, 2012 | Pubmed ID: 22507641
Immunotherapy Apr, 2012 | Pubmed ID: 22512624
1Center for Cell and Gene Therapy, Baylor College of Medicine ,
2Pathology and Immunology, Baylor College of Medicine ,
3Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center,
4Medicine, Baylor College of Medicine ,
5Department of Pediatrics, Baylor College of Medicine
ÜBER JoVE
Copyright © 2024 MyJoVE Corporation. Alle Rechte vorbehalten